Assignee
FORUM PHARMACEUTICALS INC
US·9 granted patents·11 pending applications·2 citations·filing 2012–2017
Top patents by PatentIndex Score
20 records- 0175US9265767B21,2-disubstituted heterocyclic compoundsFORUM PHARMACEUTICALS INC·Filed 2014·Granted Feb 23, 2016·1 cites·10 claims
- 0273US2015265583A1Treatment of Cognitive Disorders with (R)-7-Chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts ThereofFORUM PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0372US8946222B2Phenoxymethyl heterocyclic compoundsFORUM PHARMACEUTICALS INC·Filed 2012·Granted Feb 3, 2015·1 cites·10 claims
- 0469US2018271844A1Treatment of Cognitive Disorders with (R)-7-Chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts ThereofFORUM PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0566US2015344467A15- and 6-membered heterocyclic compoundsFORUM PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0663US8933074B21,2-disubstituted heterocyclic compoundsFORUM PHARMACEUTICALS INC·Filed 2013·Granted Jan 13, 2015·0 cites·16 claims
- 0759US9193749B2Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitorsFORUM PHARMACEUTICALS INC·Filed 2013·Granted Nov 24, 2015·0 cites·2 claims
- 0859US2015322069A1Phenoxymethyl heterocyclic compoundsFORUM PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0958US9585877B2Methods of maintaining, treating or improving cognitive functionFORUM PHARMACEUTICALS INC·Filed 2013·Granted Mar 7, 2017·0 cites·40 claims
- 1058US2017313694A1Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride MonohydrateFORUM PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1157US9550767B2Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrateFORUM PHARMACEUTICALS INC·Filed 2016·Granted Jan 24, 2017·0 cites·20 claims
- 1257US9273044B2Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrateFORUM PHARMACEUTICALS INC·Filed 2015·Granted Mar 1, 2016·0 cites·44 claims
- 1354US2017000749A1Methods for Treating Cognitive Disorders Using Inhibitors of Histone DeacetylaseFORUM PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1450US2016222026A1Dibenzo[B,F][1,4]oxazepin-11-yl-N-Hydroxybenzamides as HDAC InhibitorsFORUM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1547US2015126546A1Treatment of Cognitive Disorders with Certain Alpha-7 Nicotinic Acid Receptors in Combination with Acetylcholinesterase InhibitorsFORUM PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1639US10370370B2Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptorsFORUM PHARMACEUTICALS INC·Filed 2016·Granted Aug 6, 2019·0 cites·13 claims
- 1738US10428062B2Geminal substituted aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptorsFORUM PHARMACEUTICALS INC·Filed 2016·Granted Oct 1, 2019·0 cites·13 claims
- 1838US2017050980A1Oxadiazine compounds and methods of use thereofFORUM PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1937US2017247393A1Aminoisoxazoline Compounds as Agonists of Alpha7-Nicotinic Acetylcholine ReceptorsFORUM PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2028US2016002250A1Polymorphs and salts of a compoundFORUM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →